Fortis Inc. (FTS:CA) unveils a $28.8B, 5-year capital plan targeting 7% annualized rate base growth and continued low-risk project execution. FTS maintains its 52-year dividend growth streak, announcing a 4% increase and targeting 4-6% annual dividend growth through 2030. Recent results highlight stable earnings, strong U.S. operations, and a resilient regulatory profile, supporting Fortis' premium valuation among peers.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against KBR, Inc. (“KBR” or “the Company”) (NYSE: KBR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of KBR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against RCI Hospitality Holdings, Inc. (“RCI” or “the Company”) (NASDAQ: RICK) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of RICK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

T1 Energy Inc. ( TE ) Q3 2025 Earnings Call November 14, 2025 8:00 AM EST Company Participants Jeffrey Spittel - Executive VP of Investor Relations & Corporate Development Daniel Barcelo - CEO & Chairman Otto Erster Bergesen Evan Calio - Chief Financial Officer Conference Call Participants Philip Shen - ROTH Capital Partners, LLC, Research Division Gregory Lewis - BTIG, LLC, Research Division Sean Milligan - Needham & Company, LLC, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the T1 Energy Third Quarter 2025 Earnings Conference Call.

Vistagen Therapeutics' intranasal pherine drugs target nose-to-brain circuits. This taps into neuropsychiatric, women's health, and oncology indications. Their lead asset is Fasedienol, which is in Phase 3 for SAD. Its PALISADE-3 data may enable a possible NDA submission during 2026. The rest of VTGN's pipeline includes Itruvone, PH80, and PH284. However, I believe VTGN's tight runway will force them to prioritize Fasedienol's R&D.

Iren Limited (IREN) is a rapidly growing dual data center business with a unique blend of Bitcoin mining and AI/HPC hosting operations. IREN's vertical integration, secured 2.9GW power capacity, and strong financing position it well for future growth, despite recent share price volatility. Valuation suggests significant upside potential if execution matches guidance, with a forward P/S ratio becoming attractive by 2027.

Expects Registration Statement to be Effective by Expiration Date MIAMI , Nov. 18, 2025 /PRNewswire/ -- Lennar Corporation (NYSE: LEN and LEN.B) ("Lennar") confirmed today that in view of the reopening of the U.S. federal government, Lennar is proceeding as previously announced with the offer to exchange the approximately 20% of the total outstanding shares of Millrose Properties, Inc. (NYSE: MRP) ("Millrose") it owns for outstanding shares of Lennar Class A common stock (the "Exchange Offer"). The Exchange Offer is scheduled to expire at 12:00 midnight, New York City time, on November 21, 2025 (the "Expiration Date").

Cleveland Hopkins International Airport upgrades to improve critical infrastructure DALLAS , Nov. 18, 2025 /PRNewswire/ -- Jacobs (NYSE: J) has been selected to lead program and construction management services for phase one of a $1.6 billion modernization of Cleveland Hopkins International Airport (CLE). The transformative program, CLEvolution, is designed to reimagine the airport experience for millions of travelers by modernizing aging infrastructure enhancing accessibility and passenger flow at Ohio's most traveled airport.

Kikoff's One Million-Plus Members will be Equipped to Achieve their Personalized Credit Score Goals and Advance their Financial Health ATLANTA and SAN FRANCISCO , Nov. 18, 2025 /PRNewswire/ -- Equifax ® (NYSE: EFX) and Kikoff , a personal finance platform that expands access to credit and financial services, today announced that Optimal Path ™, the interactive score planner introduced by Equifax earlier this year, will be integrated into the Kikoff platform and rolled out to Kikoff's community of over one million customers. Leveraging the power of The Equifax Cloud ™ and patented EFX.AI capabilities, Optimal Path will integrate with each …

NEW YORK--(BUSINESS WIRE)--PVH Corp. Announces CFO Transition.

Shareholders should contact the firm immediately as there may be limited time to enforce your rights Shareholders should contact the firm immediately as there may be limited time to enforce your rights

Medtronic raised its fiscal-year outlook after logging higher profit and sales in its latest quarter, boosted by robust demand across end markets and healthy procedure volumes.

Silver slips near key support as gold weakens and Fed rate-cut odds fall, with traders watching major U.S. data for clues on sentiment and short-term direction.

The Goldman Sachs Conviction List is a curated list of stocks that the firm's research team believes have a high likelihood of outperforming the market.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of JSPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

Certara, Inc. ( CERT ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:30 AM EST Company Participants William Feehery - CEO & Director Conference Call Participants David Windley - Jefferies LLC, Research Division Presentation David Windley Jefferies LLC, Research Division Okay. Good morning, everybody.

PIRAEUS, Greece, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Navios Maritime Partners L.P. (“Navios Partners”) (NYSE: NMM), an international owner and operator of dry cargo and tanker vessels, today reported its financial results for the third quarter and nine month period ended September 30, 2025.

Micron (MU) is positioned to benefit from a DRAM supply crunch driven by surging AI demand, supporting a continued boom phase into FY26. MU's stock has more than doubled in the past year, and a significant supply shortage is expected to persist until new capacity ramps up in FY27. Despite stretched valuations, MU remains a strong momentum play, with a buy rating justified by robust revenue and margin growth forecasts through FY26.

Social media platform X was down for thousands of users in the US, according to Downdetector.

DeFi Development Corp (DFDV) remains a Buy, now trading at a significant discount to NAV after a 54% stock price decline. DFDV's SOL-focused treasury model generates strong staking yields, with Q3 revenue up 648% year-over-year and SPS accumulation continuing to grow. Recent developments include a warrant-based dividend, preferred stock offering, and the launch of a Treasury Accelerator program to drive future growth.